End to Cancer

[jocko699]

Wouldn't it be great if it is true?

https://www.jpost.com/HEALTH-SCIENCE...und-one-578939

[JustRalph]

I read this earlier today.

Seems like I’ve read this article ten times over the last 20 years

[chadk66]

Far too many types/kinds of cancer to find cures for them all in any of our lifetimes.

[fast4522]

Originally Posted by chadk66

Far too many types/kinds of cancer to find cures for them all in any of our lifetimes.

I agree with both you and JR, but think Israel is just the right environment for it to happen. Here in the States it is all about the buck.

[chadk66]

Originally Posted by fast4522

I agree with both you and JR, but think Israel is just the right environment for it to happen. Here in the States it is all about the buck.

yea I don't think the cures they do find will come from this country.

[jocko699]

Originally Posted by chadk66

yea I don't think the cures they do find will come from this country.

Completely agree with this sadly. Too much bureaucratic BS in this country.

[Buckeye]

I hope it's true and remember, one of the many fantastic claims here is the treatment is keyed to each individual's problem.

[Jeff P]

At some point in the future I wouldn't be surprised if one of the 'Big Pharma' drug companies purchased all rights to the new technology.

It wouldn't be the first time.

Link to Gilead Sciences Wikipedia page:
https://en.wikipedia.org/wiki/Gilead_Sciences

2010 to 2019

In 2010, the company acquired CGI Pharmaceuticals for $120 million, expanding Gilead's research expertise into kinase biology and chemistry. Later that year, the company acquired Arresto Biosciences, Inc. for $225 million, obtaining developmental-stage research for treating fibrotic diseases and cancer.[16]

In 2011, the company acquired Calistoga Pharmaceuticals for $375 million ($225 million plus milestone payments). The acquisition boosted Gilead's oncology and inflammation areas.[17] Later that year, Gilead made its most important acquisition — and most expensive to date — with the $10.4 billion purchase of Pharmasset, Inc. This transaction helped cement Gilead as the leader in treatment of the hepatitis C virus by giving it control of sofosbuvir (see below).

and:

Sovaldi and Harvoni

The drug sofosbuvir had been part of the 2011 acquisition of Pharmasset. In 2013, the FDA approved this drug, under the trade name Sovaldi, as a treatment for the hepatitis C virus. Forbes magazine ranked Gilead its number 4 drug company, citing a market capitalization of US$113 billion and stock appreciation of 100%, and describing their 2011 purchase of Pharmasset for $11 billion as “one of the best pharma acquisitions ever”.[28] Deutsche Bank estimated Sovaldi sales in the year's final quarter would be $53 million,[29] and Barron's noted the FDA approval and subsequent strong sales of the “potentially revolutionary” drug as a positive indicator for the stock.[30]

On July 11, 2014, the United States Senate Committee on Finance investigated Sovaldi's high price ($1,000 per pill; $84,000 for the full 12-week regimen). Senators questioned the extent to which the market was operating “efficiently and rationally”, and committee chairman Ron Wyden (D-Oregon) and ranking minority member Chuck Grassley (R-Iowa) wrote to CEO John C. Martin asking Gilead to justify the price for this drug.[31] The committee hearings did not result in new law, but in 2014 and 2015, due to negotiated and mandated discounts, Sovaldi was sold well below the list price.[32] For poorer countries, Gilead licensed multiple companies to produce generic versions of Sovaldi; in India, a pill's price was as low as $4.29.[33]

Gilead later combined Sovaldi with other antivirals in single-pill combinations. First, Sovaldi was combined with ledipasvir and marketed as Harvoni. This treatment for hepatitis C cures the patient in 94% to 99% of cases (HCV genotype 1).[34] By 2017, Gilead was reporting drastic drops in Sovaldi revenue from year to year, not only because of pricing pressure but because the number of suitable patients decreased.[35] Later single-pill combinations were Epclusa (with velpatasvir) and Vosevi (with velpatasvir and voxilaprevir).

This or something like it may turn out to be the real deal. (I really hope that's the case.)

Something tells me if and when a cure for cancer finally does come along: It won't be cheap, or even readily available - because some big drug company will have bought all rights to the technology from the original developers (who started out with altruistic intentions.)




-jp

.

[Buckeye]

That's one of the negative arguments.

The other was already stated, we don't know how to create life which is death in the end.

I still hope maybe these guys have come up with something similar to the discovery and creation of antibiotics.

[boxcar]

Originally Posted by chadk66

yea I don't think the cures they do find will come from this country.

Most likely not. Cancer is Big Pharm's god.

[Buckeye]

Big two arguments against solving the problem-- but we all agree don't we, eventually it will be solved.

What if they've done it?

[thaskalos]

"As many people as there are dying from cancer...there are even more people making a living from it." -- Linus Pauling

[Buckeye]

It's a problem waiting to be solved.

The argument you just made is: that's understandabe because some can make money.

I have a rather more optimistic view of it.

[thaskalos]

Originally Posted by Buckeye

It's a problem waiting to be solved.

The argument you just made is: that's understandabe because some can make money.

I have a rather more optimistic view of it.

In the ignorance of my relative youth, I too was optimistic when it came to cancer. Alas...I've gotten old, and have seen too much...

[Buckeye]

If there were no more cancer, I'd guess human life expectancy would go up by about five years.

Remember, there is still heart disease and other things.